Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 7/20 | 0.83 |
| ▸ | NADK | O95544 | 1/20 | 0.83 |
| ▸ | DOT1L | Q8TEK3 | 3/20 | 0.74 |
| ▸ | DNMT3B | Q9UBC3 | 2/20 | 0.74 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.74 |
| ▸ | PNMT | P11086 | 1/20 | 0.74 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.74 |
| ▸ | DPP4 | P27487 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.74 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.74 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.74 |
| ▸ | GAPDH | P04406 | 1/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.74 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.74 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.74 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.74 |
| ▸ | STAT6 | P42226 | 1/20 | 0.74 |
| ▸ | PI4KA | P42356 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylthioadenosine SCHEMBL29439558 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL20798030 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL29361072 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL890628 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL31388809 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL11954365 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL10013421 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL101382 | 1.00 | AHCY (0.83) | AHCYNADKDOT1LDNMT3BADORA3 | |
| Methylthioadenosine SCHEMBL7124285 | 0.95 | DOT1L (0.78) | AHCYNADKDOT1LDNMT3BPNMT | |
| Methylthioadenosine SCHEMBL20817193 | 0.91 | AHCY (0.70) | AHCYNADKDOT1LDNMT3BADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2099 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| WO-2026107412-A1 | SARCOSPAN MODULATION AND METHODS OF MEAT AND TISSUE CULTURE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-05-21 | — | — | WO | claimed |
| WO-2026088246-A1 | METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND | ＮＴＴ株式会社 | 2026-04-30 | — | — | WO | claimed |
| WO-2025217007-A1 | COMBINATION THERAPIES USING PRMT5 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF CANCER | Mirati Therapeutics, Inc. (US) | 2025-10-16 | — | — | WO | claimed |
| WO-2025217008-A1 | COMBINATION THERAPIES USING PRMT5 INHIBITORS AND SOS1 INHIBITORS FOR THE TREATMENT OF CANCER | Mirati Therapeutics, Inc. (US) | 2025-10-16 | — | — | WO | claimed |
| WO-2025217015-A1 | COMBINATION THERAPIES USING PRMT5 INHIBITORS AND KRAS G12D INHIBITORS FOR THE TREATMENT OF CANCER | Mirati Therapeutics, Inc. (US) | 2025-10-16 | — | — | WO | claimed |
| US-20250312351-A1 | COMBINATION THERAPIES USING PRMT5 INHIBITORS AND SOS1 INHIBITORS FOR THE TREATMENT OF CANCER | Mirati Therapeutics, Inc. (US) | 2025-10-09 | — | — | US | claimed |
| US-20250312343-A1 | COMBINATION THERAPIES USING PRMT5 INHIBITORS AND KRAS G12D INHIBITORS FOR THE TREATMENT OF CANCER | Mirati Therapeutics, Inc. (US) | 2025-10-09 | — | — | US | claimed |
| US-20250312344-A1 | COMBINATION THERAPIES USING PRMT5 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF CANCER | Mirati Therapeutics, Inc. (US) | 2025-10-09 | — | — | US | claimed |
| EP-4580628-A1 | COMBINATION THERAPIES USING PRMT5 INHIBITORS AND BCL-2 FAMILY INHIBITORS FOR THE TREATMENT OF CANCER | Mirati Therapeutics, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| WO-1992007570-A1 | AGENTS FOR THE TREATMENT OF DISEASES CAUSED BY PARASITIC PROTOZOA AND NEOPLASTIC DISEASES | HEALTH RESEARCH, INC. (US) | 1992-05-14 | — | — | WO | claimed |
| US-4973678-A | VASODILATORS, ANALGESICS, ANTIINFLAMMATORY, ANTIPYRETIC, ANTICOAGULANTS | NB JACKETS DE PUERTO RICO (US) | 1990-11-27 | — | — | US | claimed |
| EP-0387756-A1 | Use of 5'-deoxy-5'-methylthioadenosine s-adenosylmethionine and their salts in the preparation of seborrhea-reducing pharmaceutical compositions | BIORESEARCH S.p.A. (IT) | 1990-09-19 | — | — | EP | claimed |
| EP-0387757-A2 | Use of 5'-deoxy-5'methylthioadenosine, S-adenosylmethionine and their salts in the preparation of pharmaceutical compositions favouring hair growth in subjects suffering from baldness | BIORESEARCH S.p.A. (IT) | 1990-09-19 | — | — | EP | claimed |
| US-4948783-A | ORALLY ADMINISTERING ADENOSINE OR DERIVATIVE | KABUSHIKI KAISYA ADVANCE KAIHATSU KENKYUJO (JP) | 1990-08-14 | — | — | US | claimed |
| EP-0184248-B1 | SALTS OF 5'-METHYLTHIO-5'-DEOXYADENOSINE WITH LONG-ALKYL CHAIN SULPHONIC ACIDS | BIORESEARCH S.p.A. (IT) | 1989-08-02 | — | — | EP | claimed |
| EP-0184248-A2 | Salts of 5'-methylthio-5'-deoxyadenosine with long-alkyl chain sulphonic acids | BIORESEARCH S.p.A. (IT) | 1986-06-11 | — | — | EP | claimed |
| US-4562149-A | CULTIVATING A MICROORGANISM IN LIQUID CULTURE MEDIUM CONTAINING METHIONINE | NIPPON ZEON CO., LTD. (JP) | 1985-12-31 | — | — | US | claimed |
| US-4373097-A | Process for preparing adenosine derivatives of anti-inflammatory and analgesic activity | BIORESEARCH S.R.L. (IT) | 1983-02-08 | — | — | US | claimed |
| US-3962034-A | CULTURE | AJINOMOTO CO., INC. (JA) | 1976-06-08 | — | — | US | claimed |